Has a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare ...

A study of Lilly's retatrutide weight loss drug in people with heart disease did not answer a crucial question — whether it ...

Mirroring the bipartisan bill introduced in the House, the measure would require a study from the GAO on the state of men’s ...

Timothy Westlake, an emergency doctor nominated to head SAMHSA, has been active in addiction policy in Wisconsin.

New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could ...

This change is likely to lead to only modest increases in total medical expenses. However, it coincides with many other factors raising health insurance premiums,” writes Jeff Levin-Scherz.

Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. WASHINGTON — A ...

Pharmaceutical leaders are trying to convince policymakers to back off pushes for aggressive restrictions on investments in ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

A study of the long-term health impact of the Lahaina wildfires is inspiring a new model for disaster recovery and support.